FY2025 Earnings Forecast for ResMed Issued By Zacks Research

ResMed Inc. (NYSE:RMD – Free Report) – Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of ResMed in a note issued to investors on Monday, April 14th. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings per share of $9.38 for the year, […]

Leave a Reply

Your email address will not be published.

Previous post Leerink Partnrs Has Pessimistic View of Biogen Q2 Earnings
Next post SPS Commerce (NASDAQ:SPSC) Price Target Lowered to $175.00 at DA Davidson